Gebze
Ertan Ökmen
Prof.

Ertan Ökmen

He has been working as an interventional cardiologist, and also founder and director of oncocardiology department at Anadolu Medical Center since 2007.

Speciality

  • Interventional Cardiology
  • Coronary angiography and stent placement through the radial artery
  • Onco-cardiology
  • Cardiac insufficiency and heart transplant

Education

University 

İstanbul Medical School, İstanbul 
 

Specialty education 

Siyami Ersek Pulmonary and Cardiovascular Surgery Center 

Baylor College of Medicine, Texas Heart Institute, St. Lukes Episcopal Hospital, Houston, 2000: Clinical research on left ventricular assist device (Jarvik 2000).


Laboratory research on trans-myocardial laser intervention Johns Hopkins Medicine, Johns Hopkins University, 2009: Heart Failure and Cardiac Transplant Services. Heart failure and transplantation training 

Institutions Worked At

Assoc. Prof. Ertan Ökmen specialized in cardiology at Dr. Siyami Ersek Pulmonary and Cardiovascular Surgery Center, and gained the title of Associate Professor at the same hospital.  He has been serving as an interventional cardiologist at Anadolu Medical Center since 2007.  He is also the Director of Oncocardiology Department that he founded in 2011
  • Turkish Society of Cardiology
  • European Society of Cardiology
  • Fellow of the European Society of Cardiology
  • European Association of Percutaneous Cardiovascular Interventions
  • Honorary Member of the International Cardioncology Society (ICOS)
  • European Board for the Specialty of Cardiology (International Atherosclerosis Society)
  • World Heart Failure Society
  • European Society of Cardiology (ESC) Heart Failure Association
  • Istanbul Interventional Cardiology Academy

Faculty at Medical Congresses:

1. Okmen E. Prevention of the complications related to diagnostic coronary angiography. Congress of Turkish Society of Cardiology, Antalya 2004.

2. Okmen E. Left and right heart catheterization and the formulas. Congress of Turkish Society of Cardiology, Antalya 2006.

3. Okmen E. Drug eluting stents in high risk patients: Diabetic patients. National Interventional Cardiology Congress. Ankara, 2006. 

4. Okmen E. GP IIb/IIIa inhibitors in patients with acute coronary syndromes. MSD workshop. Antalya, 2006

5. Okmen E. Panelist at IVth complex percutaneous coronary interventions working day, “ostial and left main coronary artery lesions”, Istanbul 2007

6. Okmen E. Panelist at “Transradial diagnostic coronary angiography and percutaneous coronary interventions”, Transradial complex PCI. Maltepe University Faculty of Medicine, Istanbul, 2008.

7. Okmen E. Heart failure: Clinical definition and the guidelines. Anadolu Medical Center, Kocaeli, 2008.

8. Okmen E. An update for treatment of heart failure and valvular heart disease. Anadolu Medical Center, Kocaeli, 2010.

9. Session Chair at the Congresses of Turkish Society of Cardiology, 2006, 2008 2009, 2010, and 2013.

10. Okmen E. Istanbul Academy of Interventional Cardiology Course. Guiding catheters. Istanbul, 2010.

11. Okmen E. Panelist. 18th National Interventional Cardiology Congress. Antalya,2011.

12. Okmen E. Istanbul Academy of Interventional Cardiology Course. Misleading views of coronary angiography.  Istanbul, 2011.

13. Okmen E. Transradial coronary angiography and interventions. Tabriz University of Medical Sciences” “2nd International Scientific Congress of Azerbaijanian Physicians”, Tabriz , Iran September 2011.

14. Omken E. Heart Failure: Epidemics of the century. New concepts on treatment Al Sultan Medical Center Cardiovascular Conference, Istanbul, 11. Dec 2011

15. Omken E. Atrial fibrillation and new oral anticoagulant drugs. Al Sultan Medical Center Cardiovascular Conference, Istanbul, 11. Dec 2011

16. Omken E. A new pathway to the heart: transradial coronary angiography and interventions Al Sultan Medical Center Cardiovascular Conference, Istanbul, 11. Dec 2011

17. Okmen E. A new treatment modality for resistant hypertension: Catheter-Based Renal Denervation  Al Sultan Medical Center Cardiovascular Conference, Istanbul,  2011

18. Okmen E. The effect and benefits of aerobic and resistance exercise training. 3rd World Heart Failure Congress, World Heart Failure Society, Istanbul Nov 29- Dec 02, 2012, 

19. Management of Heart Failure: A Case Based Approach: Hyponatremia, panelist 3rd World Heart Failure Congress, World Heart Failure Society, Istanbul Nov 29- Dec 02, 2012

20. Management of Heart Failure: A Case Based Approach: Device-LVAD, panelist. 3rd World Heart Failure Congress, World Heart Failure Society, Istanbul Nov 29- Dec 02, 2012

21. Oncocardiology: Marmara University Oncology Conferences, Istanbul 2014

22. Okmen E: Oncocardiology: 63th European Society of Cardiovascular Surgery/ 10th UCCVS Congresses, Antalya, Turkey, 2014

23. Okmen E: concomittant drug use in cardiovascular disease; Anticancer drugs. 64th European Society of Cardiovascular and Endovascular Surgery/ 11th UCCVS Congresses. Istanbul, Turkey, 2015

Chapter in Book

1. Okmen E. Endothelium and Coronary Interventions, in The Secret Power of Life: Endothelium and Our Systems. Ed: Mustafa San. Printaş Basım AŞ, İstanbul, 2005.

2. Okmen E. Chapter 50: Postmyocardial infarction cardiogenic shock. Cardiac Surgery. Turkish Society of Cardiovascular Surgery 2011.


Publications in the International Journals

1. Valgimigli M, Biondi-Zoccai G, Tebaldi M, van’t Hof AW, Campo C, Ten Berg J, Bolognose L, Saia F, Danzi GB, Briguouri C, Okmen E, King SB, Moliterno DJ, Topol EJ Tirofiban as adjunctive therapy for acute coronary syndromes and percutaneous coronary intervention: a meta-analysis of randomized trials. Eur Heart J 2010;31:35-49.

2. Okmen E, Kasikcioglu H, Sanli A, Uyarel H, Tartan Z, Cam N. Correlations between cardiac troponin I cardiac troponin T and creatine phosphokinase MB elevation following successful percutaneous coronary intervention and prognostic value of each marker. Journal of Invasive Cardiology 2005;17:63-67.

3. Uyarel H, Cam N, Okmen E, Kasikcioglu H, Tartan Z, Akgul O, Simsek D, Cetin M, Bozbeyoglu E, Buturak A, Uzunlar B. Level of Selvester QRS score is predictive of ST-segment resolution and 30-day outcomes in patients with acute myocardial infarction undergoing primary coronary intervention. American Heart Journal 2006;151:1239. e1-7

4. Uyarel H, Uslu N, Okmen E, Tartan Z, Kasikcioglu H, Dayi SU, Cam N. QT dispersion in sarcoidosis. Chest 2005;128:2619-2625. 

5. Okmen E, Sanli A, Kasikcioglu H, Dayi S, Cam N. Effects of glycoprotein IIb/IIIa inhibition with tirofiban on minor myocardial injury in successful coronary angioplasty. Cardiology 2004;102;18-23. 

6. Okmen E, Gurol T, Erdinler I, Sanli A, Cam N. New-onset conduction defects and relation with in-hospital major cardiac events in unstable angina pectoris. Coronary Artery Disease 2003;14:521-5.

7. Okmen E, Sanli A, Kasikcioglu H, Uyarel H, Cam N. Left main coronary artery aneurysm associated with extensive coronary arterial calcification: Case report and review. International Journal of Cardiovascular Imaging 2004;20:231-5. 

8. Okmen E, Cam N, Sanli A, Yapici F, Uyarel H, Vural M, Ozturk R. Effects of direct stent implantation and conventional stent implantation on minor myocardial injury. Angiology 2004;55:495-91.

9. Okmen E, Sanli A, Tartan Z, Uyarel H, Kasikcioglu H, Cam N. Long-term follow-up after angiographically successful coronary stenting: Direct stent versus conventional stent implantation. Japanese Heart Journal 2004;45:53-61.

10. Erdinler E, Afsar N, Sanli A, Okmen E. Asystole associated with cluster headache. Canadian Journal of Cardiology 2004;13:1369-70.

11. Okmen E. Comment on “The additive value of tirofiban administered with the high-dose bolus in the prevention of ischemic complications during high-risk coronary angioplasty: the ADVANCE Trial. J Am Coll Cardiol 2004; 44(1):14-9” Evidence Based Cardiovascular Medicine 2004;8:355-356.

12. Okmen E, Ozen E, Uyarel H, Sanli A, Tartan Z, Cam N. Effects of enoxaparin and nadroparin on major cardiac events in high-risk unstable angina treated with glycoprotein IIb/IIIa inhibitor. Japanese Heart Journal 2003;44:899-906.

13. Oguz E, Akyol A, Okmen E. Inhibition of biventricular pacing by far-field left atrial activity sensing: Case Report. Pacing and Clinical Electrophysiology 2002;25:1517-9.

14. Okmen E, Cakmak M, Celik S, Yapici F, Erdinler I, Ozturk R, Cam N. Laser angioplasty in a right coronary artery stent restenosis with the guidance of left internal mammary artery contrast injection: Case report. Catheterization and Cardiovascular Intervention 2001; 53:71-74.

15. Okmen E, Cakmak M, Tartan Z, Cam N. Effects of glycoprotein IIb/IIIa inhibition on clinical stabilization parameters in patients with unstable angina and non-Q-wave myocardial infarction. Heart Vessels 2003;18:117-22.

16. Erdinler I, Okmen E, Oguz E, Akyol A, Gurkan K, Ulufer T. Differantiation of narrow QRS complex tachycardia types using 12-lead electrocardiogram. Annals of Noninvasive Electrocardiology 2002;7:120-6. 

17. Celik S, Tayyareci G, Okmen E, Zor A, Unal Dayi S. A case of biventricular hypertrophic obstructive cardiomyopathy. International Journal of Cardiology 2002;83:269-71.

18. Okmen E, Cam N, Erdinler I, Zor U, Tunar H, Sanli A, Uyarel H. Effects of glycoprotein IIb/IIIa inhibition on QT dispersion in patients with unstable angina and non-Q-wave myocardial infarction. International Journal of Angiology 2002;11:144-9.

19. Okmen E, Erdinler I, Oguz E, Akyol A, Cam N. An unusual cause of reflex cardiovascular syncope: Vagal paraganglioma. Annals of Noninvasive Electrocardiology 2003;8:173-176. 

20. Erdinler I, Okmen E, Zor U, Zor A, Ketenci B, Oguz E, Aytekin S, Ulufer T. Pacemaker related endocarditis: Analysis of seven cases. Japanese Heart Journal 2002;43:475-85.

22. Erdinler I, Akyol A, Okmen E, Oguz E, Gurkan K, Ulufer T. Long-term follow-up of pacemakers with autocapture pacing system. Japanese Heart Journal. 2002;43:631-41.

22. Okmen E, Oguz E, Erdinler I, Sanli A, Cam N. Left circumflex coronary artery bridging. Japanese Heart Journal 2002;43:423-427.

23. Okmen E, Cam N, Erdinler I, Celik S, Sanli A, Ozturk R. Coronary artery aneurysm associated with descending thoracic aneurysm. Internatinal Journal of Angiology 2002;11:89-91.

24. Erdinler I, Okmen E, Turek O, Yapici F, Ozler A, Cam N, Ulufer T. Tricuspid valve perforation by permanent pacemaker lead. Angiology. 2005;56:619-21.

25. Aydin A, Okmen E, Erdinler I, Sanli A, Cam N. A case of adrenal adenoma presenting with ventricular fibrillation. Tex Heart Inst J. 2005;32:85-7.

26. Uyarel H, Okmen E, Tartan Z, Kasikcioglu H, Dayi SU, Karabulut A, Uzunlar B, Samur H, Cam N. The role of angiotensin converting enzyme genotype in coronary artery ectasia. Int Heart J. 2005;46:89-96.

27. Uyarel H, Kasikcioglu H, SU Dayi, Tartan Z, Karabulut A, Uzunlar B, Samur H, Sari I, Okmen E, Cam N. Anxiety and p wave dispersion in a healthy young population. Cardiology 2005;104:162-168.

28. Kasikcioglu HA, Unal S, Tartan Z, Uyarel H, Okmen E, Kasikcioglu E, Cam N. Effects of levosimendan on left ventricular functional remodelling and exercise intolerance: a tissue Doppler study. J Int Med Res. 2005;33:397-405

29. Okmen E, Erdinler I, Oguz E, Turek O, Akyol A, Ulufer T. An electrocardiographic algorithm for determining the location of pacemaker electrode in patients with right bundle branch block configuration during permanent ventricular pacing. Angiology 2006;57:623-30.

30. Okmen E, Cam N, Sanli A, Unal S, Tartan Z, Vural M. Cardiac troponin I increase after successful percutaneous coronary angioplasty: Predictors and long-term prognostic value. Angiology 2006;57:161-9.

31. Okmen, E, Sanli A, Uyarel H, Dayi SU, Tartan Z, Cam, N. Impacts of glycoprotein IIb/IIIa inhibition on QT dispersion after successful percutaneous coronary intervention. Angiology. 2006;57:273-81.

32. Uyarel H, Ozdol C, Gencer AM, Okmen E, Cam N. Acute alcohol intake and QT dispersion in healthy subjects. J Stud Alcohol. 2005;66:555-8

33. Dayi SU, Kasikcioglu H, Uslu N, Tartan Z, Uyarel H, Terzi S, Hobikoglu G, Okmen E, Cam N. Influence of weight loss on myocardial performance index. Heart Vessels. 2006;21:84-8.

34. Uyarel H, Okmen E, Cobanoglu N, Karabulut A, Cam N. Effects of anxiety on QT dispersion in healthy young men. Acta Cardiol. 2006;61:83-7

35. Uyarel H, Uzunlar B, Dayi SU, Tartan Z, Kasikcioglu H, Akgul O, Simsek D, Erdem I, Okmen E, Cam N. Effect of tirofiban therapy on ST segment resolution and clinical outcomes in patients with ST segment elevated acute myocardial infarction undergoing primary angioplasty. Cardiology. 2006;105:168-75.

36. Ozay B, Okmen AS, Idiz M, Okmen E, Ketenci B, Yekeler I. Aorta-Right Atrial Fistula after VSD Operation. Thorac Cardiovasc Surg. 2007;55:122-3.

37. Okmen AS, Okmen E. Quadricuspid aortic valve without severe dysfunction despite advanced age. Tex Heart Inst J 2009;36:486-8.


Abstracts in the International Congresses

1. Croitoru M, Myers TJ, Gregoric ID, Miller K, Okmen E, Alev C, Kadipasaoglu KA, Frazier OH. End systolic pressure volume relationship as predictor of ventricular recovery with Jarvik 2000. ASAIO Congress. ASAIO Journal 2001;47:141. 

2. Cam N, Okmen E, Kasikcioglu H, Uyarel H, Erdem I, Vural M. The efects of direct stent implantation and conventional stent implantation on minor myocardial injury in percutaneous coronary intervention. J Am Coll Cardiol 2002;39:320B

3. Okmen E, Cam N, Kasikcioglu H, Erdinler I, Sanli A, Uyarel H, Ozturk R. Effects of glycoprotein IIb/IIIa receptor ınhibition with tirofiban on minor myocardial damage in percutaneous coronary angioplasty. J Am Coll Cardiol 2002;39:8B.

4. Okmen E, Cam N, Erdinler I, Oguz E, Zor U, Sanli A, Uyarel H. Effects of Glycoprotein IIb/IIIa inhibition on QT dispersion in patients with unstable angina and non-Q-wave myocardial infarction. J Am Coll Cardiol 2002;39:114B.

5. Okmen E, Gurol T, Erdinler I, Oguz E, Akyol A, Cam N, Gurkan K, Ulufer T. Atrioventricular and intraventricular conduction defects and their relation with in-hospital major cardiac events in non-ST elevation coronary syndromes. J Am Coll Cardiol 2002;39:113B.

6. Aksoy M, Goktekin O, Erdinler I, Gursurer M, Pinarli AE, Okmen E, Yesilcimen K, Ulufer T, Ersek B. Mechanism of increased QT dispersion and its prognostic value in patients with coronary artery disease using Tl-201 scintigraphy. XIXth Congress of The European Society of Cardiology, August 1997.

7. Aksoy M, Pinarli AE, Gursurer M, Guler N, Okmen E, Yesilcimen K, Ersek B. Identification of high-risk patients by a new exercise-testing index: stress recovery index. XIXth Congress of The European Society of Cardiology, August 1997.

8. Uyarel H, Uslu N, Tartan Z, Unal Dayi S, Okmen E, Samur H, Karabulut A, Cam N. QT dispersion in sarcoidozis. 17th Asia Pacific Congress on Diseases of the Chest. Chest Supplement  OP40. August 2003.

9. Okmen E, Kasikcioglu H, Sanli A, Uyarel H, Tartan Z, Cam N. Correlations between cardiac troponin I cardiac troponin T and creatine phosphokinase MB elevation following successful percutaneous coronary intervention and prognostic value of each marker. Mediterannean Association of Cardiology and Cardiovascular Surgery Congress. Heart Surg Forum 2004;7 (Suppl 2) B32.

10. Kasikcioglu HA, Unal S, Tartan Z, Uyarel H, Okmen E, Kasikcioglu E, Cam N. Effects of levosimendan on left ventricular function and exercise capacity Eur J Echocardiography Suppl, 259, 2005.

11. Dayi Unal S, Kasikcioglu H, Uslu N, Tartan Z, Uyarel H, Okmen E, CamN. Effect of weight loss with orlistat on aortic stiffness. Eur J Echocardiography Suppl, 923, 2005.

12. Uyarel H, Ozdol C, Karabulut A, Okmen E, Cam N. Acute alcohol intake and P-wave dispersion in healthy men. XIth Congress of ISHNE and at the XXXIInd Congress of the ISE Gdansk/Poland, 2005.

13. Tartan Z, Orhan G, Kasikcioglu H, Unal S, Ciloglu F, Uyarel H, Okmen E, Cam N, Aykut S. The corelation of paroxanase enzyme activity with angiographic severity and extent of coronary heart disease in diabetics. XIV International Symposium on Atherosclerosis, 528, 2006, Rome, Italy

14. Okmen A Sanli, Yildirim A, Soylu O, Celik, S, Okmen E, Tezel T. Comparison of resting and exercise strain rate  echocardiography parameters of patients with and without left ventricular hypertrophy associated with diastolic dysfunction. European Society of Cardiology Heart Failure Congress. Lisbon 2005, Portugal.

15. Okmen A Sanli, Yildirim A, Soylu O, Celik, S, Okmen E, Tezel T. Effects of left ventricular hypertrophy on left ventricular pulse wave Doppler filling parameters during resting and exercise in patients with diastolic dysfunction. Second Mediterranean Meeting on Hypertension and Atherosclerosis, Antalya 2005.

16. Okmen A Sanli, Yildirim A, Soylu O, Celik, S, Okmen E, Tezel T. Effects of exercise performed by bicycle Ergometer on diastolic, filling parameters in patients with diastolic dysfunction. Second Mediterranean Meeting on Hypertension and Atherosclerosis, Antalya 2005.

17. Okmen A Sanli, Yildirim A, Soylu O, Celik, S, Okmen E, Tezel T. Effects of left ventricular hypertrophy associated  with diastolic dysfunction on index myocardial performance. Second Mediterranean Meeting on Hypertension and Atherosclerosis, Antalya 2005.

18. Okmen A Sanli, Yildirim A, Soylu O, Celik, S, Okmen E, Tezel T. Relationship between brain natriuretic peptide levels and echocardiographic characteristics in patients with diastolic dysfunction associated with left ventricular hypertrophy. Second Mediterranean Meeting on Hypertension and Atherosclerosis, Antalya 2005.


Publications in the National Journals

1. Okmen E, Vural M, Unal Dayi S, Sanli A, Erdem I, Kibaroglu A, Tatlici G, Cam N. Effects of percutaneous coronary intervention on mycoplasma pneumoniae antibody levels. MN Cardiology 2003;5:354-9.

2. Okmen E, Uyarel H, Sanli A, Sari I, Erdem I, Cam N. A young case with acute coronary syndrome without any known risk factor. Archives of The Turkish Society of Cardiology 2002;320-323.

3. Okmen E, N Cam. Direct stent implantation: Feasibility advantages and disadvantages. Anatolian Journal of Cardiology 2002;3:237-243.

4. Okmen E, Erdinler I, Zor U, Zor A. “Antitachycardia pacing” algorithms efficacy safety and usage. Archives of The Turkish Society of Cardiology 2002;30:498-504.

5. Cam N, Okmen E. How to treat patients with low HDL cholesterol levels. Archives of The Turkish Society of Cardiology 2002;30:558-567.

6. Okmen E, Tunar H, Erdinler I, Kasikcioglu, Sanli A, Tartan Z, Ozturk R, Cam N. Effects of glycoprotein IIb/IIIa receptor inhibition on early and long-term prognosis in high risk patients with non-ST elevation acute coronary syndromes without early invasive intervention. Archives of The Turkish Society of Cardiology 2002;30:22-29.

7. Okmen E, Erdinler I, Cam N. Arrhythmogenic right ventricular dysplasia and therapeutical approaches. (Review). Archives of the Turkish Society of Cardiology, 2000;28:706-717.

8. Okmen E, Cakmak M, Celik S, Tunar H, Yilmaz H, Erdinler I, Ozturk R, Cam N. Effects of glycoprotein IIb/IIIa Inhibition with tirofiban on in-hospital major cardiac events in patients with unstable angina pectoris and non Q wave myocardial infarction. MN Cardiology 2001 8;3:175-180.

9. Okmen E, Erdinler I, Eksinar S, Celik SE, Oguz E, Ulufer T. Comparison of the effects of DDDR and VVIR pacemakers on cardiac functions using echocardiography and exercise stress testing: a randomised crossover study. Archives of The Turkish Society of Cardiology, 1999;27: 672-676. 

10. Okmen E, Erdinler I, Eksinar S, Celik SE, Oguz E, Ulufer T. Quality of life during DDDR pacing versus VVIR Pacing. The Bulletin of Siyami Ersek Cardiovascular and Thoracic Surgery Center 1999;7:153-60.

11. Erdinler I, Okmen E, Akyol A, Oguz E, Gurkan K, Ulufer T. Effects of radiofrequency catheter ablation on repolarozation dispersion in Wolf Parkinson White syndrome. MN Kardiyoloji 2001;8:370-373.

12. Erdinler I, Okmen E. Right bundle branch block pattern on electrocardiography in patients with permanenet pacemaker. Turkish Journal of Arrhythmia Pacemaker and Electrophysiology 2003;1:104-6.

13. Celik S, Okmen E, Gurol T, Tartan Z, Cam N. Development of myocardial injury and ventricular arrhythmia following extracorporeal litotripsy. Archives of The Turkish Society of Cardiology 2002;30:449-451.

14. Erdinler I, Okmen E, Akyol A. Treatment of neurocardiogenic syncope with permanent pacemaker implantation. (Review). Archives of the Turkish Society of Cardiology, 2000;28:186-189.

15. Erdinler I, Okmen E, Akyol A, Oguz E, Gurkan K, Ulufer T. Electrocardiographic abnormalities occurring after radiofrequency catheter ablation of manifest accessory pathways in Wolff-Parkinson-White Syndrome. Archives of the Turkish Society of Cardiology, 2000;28:495-500. 

16. Celik S, Okmen E, Tayyareci G, Akgoz H, Unal S, Cam N, Ulusoy T. The relationship between left ventricular outflow tract pressure gradient and the severity and frequency of arrhythmias in hypertrophic cardiomyopathy. MN Cardiology 2001 8;1:17-22.

17. Ozergin A, Unal D, Okmen E, Cagıl A. Ventricular septal defect after acute posterior myocardial infarction. The Bulletin of Siyami Ersek Cardiovascular and Thoracic Surgery Center 1994; 2:59-60.

18. Erdinler I, Emre A, Akyol A, Okmen E, Narin A. Predictive value of the ECG intervals reflecting ventricular depolarisation and repolarisation. The Bulletin of Siyami Ersek Cardiovascular and Thoracic Surgery Center 1997; 5:88-93. 

19. Tarkun I, Okmen E, Kabasakal L, Aydın N, Kılınc E. Free radical and antioxidant levels in acute myocardial infarction. The Bulletin of Siyami Ersek Cardiovascular and Thoracic Surgery Center 1997;5:98-102. 

20. Erdinler I, Akyol A, Okmen E, Gurkan K, Ulufer T. Treatment of malign vasovagal syncope with dual chamber rate drop response pacemaker. Archives of the Turkish Society of Cardiology 1999;27:711-713.

21. Erdinler I, Akyol A, Okmen E, Demirtas M, Unal S, Oguz E, Turek O, Emre A, Ulufer FT. Permanent pacemaker implantation after cardiac surgery. Archives of the Turkish Society of Cardiology 2000;28:126-130.

22. Celik S, Hobikoglu G, Akgoz H, Unal S, Terzi S, Okmen E, Aksoy M, Tayyareci G, Ersek B, Ulusoy T. Evaluation of the relationship between new QRS score and coronary artery disease and myocardial ischemia. MN Cardiology 2001;8:23-28.

23. Erdinler I, Karahan A, Zor U, Okmen E. Cardiac pacemaker related endocarditis and therapeutical approach. Archives of The Turkish Society of Cardiology 2001;29:577-583.

24. Yapici F, Tarhan A, Yilmaz M, Serbetcioglu A, Okmen E, Bilgen F, Ozler A: High take-off posterior descending coronary. TGKDCD 2000;8:602-4.

25. Oguz E, Erdinler I, Akyol A, Okmen E, Uyarel H, Ozer O, Tartan Z, Gurkan K, Ulufer T. Feasibility and safety of biventricular pacing by transvenous route in patients with dilated cardiomyopathy. Archives of The Turkish Society of Cardiology 2002;30: 177-182.

26. Vural M, Dayi S, Tartan Z, Kasikcioglu H, Okmen E, Cam N. A case of dilated cardiomyopathy associated with volatile substance abuse. Archives of The Turkish Society of Cardiology 2003;31:234-238.

27. Uyarel H, Erdem I, Dayi SU, Kasikcioglu H, Tartan Z, Akgul O, Simsek D, Karabulut A, Gurdogan M, Okmen E, Cam N. The effect of glycoprotein IIb/IIIa inhibition on ST-segment resolution following successful primary percutaneous coronary interventions. Arch Turk Soc Cardiol 2005;33:204-211.

28. Okmen AS, Yildirim A, Soylu O, Celik SE, Okmen E, Tezel T. The effect of exercise on a bicycle ergometer on diastolic filling parameters in patients with diastolic dysfunction. Arch Turk Soc Cardiol 2005;33:268-275.

29. Uyarel H, Ozdol C, Karabulut A, Okmen E, Cam N. Acute alcohol intake and P-wave dispersion in healthy men. Anadolu Kardiyol Derg. 2005;5(4):289-93.

30. Dayi ŞÜ, Kaşıkçıoğlu H, Uslu N, Tartan Z, Uyarel H, Ökmen E, Akgül Ö, Buturak A, Çam N. The effect of dietary weight loss treatment supported by orlistat on the aortic stiffness. Turkish Society of Cardiology Research 2005;33:217-221

31. Uyarel H, Karabulut A, Okmen E, Cam N. Familial Mediterranean fever and acute anterior myocardial infarction in a young patient. Anadolu Kardiyol Derg. 2006;6:272-4.

32. Ökmen E. Monitoring and treatment of pregnant women with cyanotic and acyanotic congenital heart disease. J Int Med Sci 2005; 1:31-38.

33. Uyarel H, Kaşıkçıoğlu H, Tartan Z, Özgül Ö, Şimşek D, Çelik M, Bozbeyeoğlu E, Ökmen E, Çam N. The effect of glucose level on admission on ST segment resolution following successful primary percutaneous coronary intervention. Medical Network Kardiyoloji. 2006;3:

34. The relationship between high sensitivity C-reactive protein levels on admission and ST segment resolution following succesful primary percutaneous coronary intervention. Uyarel H, Kaşıkçıoğlu H, Tartan Z, Akgül Ö, Şimşek D, Çetin M, Bozbeyoğlu E, Buturak A, Uzunlar B, Ökmen E, Çam N. Türk Kardiyol Dern Arş 2006; 34: 406-412

35. Okmen E. Did drug eluting stents change the management of coronary artery disease in diabetic patients, Review. Turkish Journal of Thoracic and Cardiovascular Surgery. 2008:16:198-204.

36. Ökmen AS, Ökmen E. Drug eluting stents in multivessel disease: Was one of the important fortresses of surgery conquered? Anadolu Kardiyol Derg. 2009;4:325-30.

37. Okmen AS, Okmen E. Sinoatrial node artery arising from posterolateral branch of right coronary artery: definition by screening consecutive 1500 coronary angiographies. Anadolu Kardiyol Derg. 2009;9:481-5.

38. Okmen AS, Okmen E. Split right coronary artery: a report of two cases. Turk Kardiyol Dern Ars. 2010;38(1):38-40.

39. Okmen AS, Okmen E. Coexistence of anomalous sinus node artery originating from the left anterior descending artery and agenesis of the right coronary artery. Turk Kardiyol Dern Ars. 2010;38:112-114

Press & News

8 Nisan 2016 Cuma
HABERTÜRK
Düzenli egzersizin faydaları saymakla bitmiyor

1 Şubat 2017 Çarşamba
HABERTÜRK
Soğuk havalar ve kalp

12 Nisan 2017 Çarşamba
MİLLİYET
Kalp hastalıklarının tedavisinde yenilikler

10 Kasım 2021 Çarşamba
SÖZCÜ
Soğuk havalarda kalp krizi riski

Areas of Interest

What is Good for Low Blood Pressure? Symptoms of Low Blood Pressure

Blood pressure is an indicator that measures the resistance created by the blood pumped by the heart in the blood vessels. There are two different values for this pressure: systolic and diastolic. Systolic pressure, also known as high blood pressure, measures the blood pressure during the heart's contraction. Diastolic pressure, known as low blood pressure, refers to the measurement of blood pressure during the heart's resting phase. Low blood pressure is a health issue characterized by blood pressure being lower than the normal range. For healthy individuals, the ideal blood pressure is expressed as 120/80. Here, the value of 120 indicates systolic pressure, while the value of 80 refers to diastolic blood pressure. Low blood pressure is characterized by blood pressure values lower than 90/60. In some cases, low blood pressure may indicate a serious health problem. Especially in older individuals, low blood pressure can obstruct sufficient blood flow to the heart, brain, and other vital organs. This can lead to symptoms such as dizziness, fainting, and shock. Causes of low blood pressure may include dehydration, pregnancy, heart disorders, nervous system diseases, and certain medications. To prevent and treat low blood pressure, lifestyle changes such as drinking adequate amounts of water, increasing salt intake, rising slowly from a seated position, avoiding caffeine, eating low-carbohydrate meals, exercising the leg muscles, and wearing compression stockings can be applied. In some cases, medication treatment may also be recommended by a doctor.

What is Marfan Syndrome, Its Symptoms, Causes, and Treatment

Marfan syndrome is a rare disease that primarily occurs due to genetic reasons and affects connective tissue. Connective tissue is an important structure that forms the supportive tissue in the body and holds organs together. Marfan syndrome arises from a mutation in the FBN1 gene, which encodes the protein fibrillin-1. This mutation can affect the elasticity and durability of connective tissue, leading to a range of systemic issues. Individuals with Marfan syndrome are typically tall, slender, and have long limbs. One of the most commonly affected areas is the cardiovascular system, where aneurysms and heart valve problems are frequently observed. Additionally, noticeable features may be present in the eyes, skeleton, and skin. The treatment of Marfan syndrome is prepared with input from multiple specialties, aiming to improve the patient's quality of life and manage symptoms

Heart Attack Symptoms in Women are Different

What is Heparin and What Does it Do?

Heparin is used in the treatment and prevention of many health issues such as vascular blockages, heart attacks, and strokes by preventing blood clotting. By regulating blood flow and preventing blockages, heparin use helps avoid the formation of clots. However, there are several factors to consider for the effective and safe administration of heparin treatment. Key points that should be addressed for the success of heparin therapy include correct dosage, drug interactions, and nutrition. Additionally, factors such as the patient's medical history, age, and gender play a significant role in personalizing the treatment.

What is a Murmur? How is Murmur Treatment Done?

A murmur is the general term for sounds heard during a heart examination with a stethoscope, in addition to normal heart sounds, that resemble a blowing or whooshing sound.

What is Blood Pressure? Symptoms of High and Low Blood Pressure

The heart continuously pumps blood to the body through the aorta. During this pumping process, the blood is sent through the vessels under pressure. The pressure that forms on the inner walls of the blood vessels is defined as blood pressure. Blood pressure, which can also be referred to as arterial pressure, is crucial for the adequate supply of blood to tissues and organs, enabling them to carry out vital functions. Each time the heart contracts, it pumps blood into the arteries with a certain pressure, and when the heart muscle relaxes, some pressure remains in the vessels. These two types of pressure are referred to as systolic and diastolic blood pressure. Although blood pressure can vary from person to person, the average range is expected to be 90 to 120 mm Hg for systolic blood pressure and 60 to 80 mm Hg for diastolic blood pressure. Low blood pressure, known as hypotension, usually does not pose a significant risk and rarely leads to symptomatic problems. However, a sudden drop in blood pressure can cause symptoms such as headaches and fatigue. High blood pressure, known as hypertension, is much more serious than low blood pressure and can lead to severe health problems. Before delving into the types of blood pressure, it is important to understand what blood pressure means.

What is Pulse? What Should the Ideal Pulse Rate Be?

Measuring the pulse shows how fast the heart is beating. A normal pulse beats at a regular rhythm, and its normal values can vary depending on certain factors. If the heart beats too slowly or too quickly, it may be a sign of a heart condition. Pulse measurement provides important results for detecting such problems. The pulse can be measured, particularly at the wrist.

Symptoms and Treatment Methods of Rheumatic Heart Disease (Acute Rheumatic Fever)

Acute rheumatic fever, commonly known as rheumatic heart disease, is a rheumatic condition that develops after a throat infection (pharyngitis) caused by bacteria known as group A streptococci. It typically appears 2 to 3 weeks after the pharyngitis. The disease results in inflammatory damage in organs containing connective tissue due to an abnormal inflammatory response from the body.

Thickening of the Heart Muscle

Although not widely known among the public, this is a very serious and important issue. It is defined as an increase in the mass of the heart muscle or thickening due to the accumulation of other tissues and substances within the heart muscle.

Thickening of the Heart Muscle and Hypertension

Thickening of the heart muscle is defined as an increase in the mass of the heart muscle or thickening due to the accumulation of other tissues and substances within the heart muscle. According to Cardiology Specialists at Anadolu Medical Center, the main cause of this condition, which can lead to heart failure, is hypertension. They provide insights into heart muscle thickening.

Heart Palpitations: What They Are, Causes, Symptoms, and Treatment

Heart palpitations are among the top reasons for visits to emergency rooms and cardiology clinics. The term "heart palpitations" refers to the sensation of an accelerated heartbeat, an irregular heartbeat, or a change in rhythm. Due to these changes in how the heart functions, a person may feel as if something is pounding strongly in their neck or chest. While the underlying causes of heart palpitations are generally benign, it’s important to note that, in some cases, they can be due to life-threatening conditions, so caution is necessary.

Capillary Leak Syndrome: What It Is, Causes, Symptoms, and Treatment

Capillary Leak Syndrome, known medically as Systemic Capillary Leak Syndrome (SCLS), was first described in 1960 by Dr. Bayard Clarkson, which is why it is also referred to as Clarkson’s disease. This syndrome can have a severe course due to the shock state that develops during its progression, making awareness of the condition crucial.

Hypertension: What It Is, Symptoms, and Treatment

A person's blood pressure is the force exerted by blood against the walls of arteries as it circulates through the body. Blood pressure is measured in two parts: the systolic blood pressure, commonly known as "high" blood pressure, and diastolic blood pressure, known as "low" blood pressure. The unit of blood pressure is millimeters of mercury (mmHg). Systolic blood pressure measures the maximum pressure in the arteries when the heart contracts to pump blood. Diastolic blood pressure reflects the minimum pressure in the arteries when the heart rests between beats.

Hypertension Disease

Blood pressure values above 40/90 mmHg are considered hypertension. Hypertension is a disease that leads to complications such as heart attack, stroke, heart failure, and kidney failure, and it shortens life expectancy in both men and women.

What Causes Chest Pain?

Chest pain, which can range from a dull, tight sensation to a sharp, stabbing pain, may sometimes radiate to the arm and neck. The causes of chest pain can be symptoms of various diseases. In serious problems related to the heart and lungs, the exact cause of chest pain should be determined, and immediate medical intervention is required

Angiography is not a treatment, but a diagnostic method

Angiography, which is still considered the gold standard for imaging the heart's blood vessels, plays a very important role in the diagnosis and treatment of cardiovascular diseases. Anadolu Health Center cardiology specialists emphasize that angiography is a diagnostic method aimed at revealing the narrowing or blockage of coronary vessels to determine the treatment approach. They answer questions you may have regarding angiography…